Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Massachusetts General Hospital · with Patient-Centered Outcomes Research Institute · NCT05237258

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–120 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
2300
US sites recruiting
20
Study start
June 1, 2022
Record last updated
July 25, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This research study is evaluating whether primary palliative care is an alternative strategy to specialty palliative care for improving quality of life, symptoms, mood, coping, and end of life outcomes in patients with acute myeloid leukemia (AML).

Being studied: Specialty Palliative Care; Primary Palliative Care

Conditions: Relapsed Adult AML; Primary Refractory Acute Myeloid Leukemia; High Risk Acute Myeloid Leukemia

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Patient Inclusion Criteria
  • Hospitalized patients (age ≥ 18 years) with high-risk AML defined as:
  • Patients with new diagnosis ≥ 60 years of age
  • An antecedent hematologic disorder
  • Therapy related-disease
  • Relapsed or primary refractory AML
  • Within five business days of initiating therapy with either a) intensive chemotherapy (7+3) or modification of this regimen on a clinical trial, or a similar intensive regimen requiring prolonged hospitalization; or b) hypomethylating agents +/- additional agents or modification of this regimen on a clinical trial.
  • Caregiver Inclusion Criteria
  • Adult (≥18 years) relative or friend of a participating patient who the patient identifies as living with or has in-person contact with them at least twice per week.

Exclusion Criteria

  • Patient Exclusion Criteria
  • Patients with a diagnosis of acute promyelocytic leukemia (APML)
  • Patients with AML receiving supportive care alone
  • Patients with psychiatric or cognitive conditions which the treating clinicians believe prohibits informed consent or compliance with study procedures
  • Patients seen by a palliative care clinician (MD, DO, APP) during two previous hospitalizations in the six months prior to enrollment
  • Patients expected to be discharged within 2 days

Recruiting US locations

  • University of Alabama - Birmingham

    Birmingham, AL 35294

    Site contact: Richard Taylor, PhD · rtaylor@uabmc.edu

  • Stanford University

    Stanford, CA 94305

    Site contact: Karl Lorenz, MD · kalorenz@stanford.edu

  • University of Colorado Denver I Anschutz Medical Campus

    Denver, CO 80204

    Site contact: Stacy Fischer, MD · STACY.FISCHER@CUANSCHUTZ.EDU

  • University of Miami

    Miami, FL 33146

    Site contact: Lara Traeger, PhD · ltraeger@miami.edu

  • Moffitt Cancer Center

    Tampa, FL 33612

    Site contact: Sara Tinsley-Vance, PhD · Sara.TinsleyVance@moffitt.org

  • Emory University

    Atlanta, GA 30322

    Site contact: Dio Kavalieratos, MD · d.kavalieratos@emory.edu

  • Northwestern University

    Evanston, IL 60208

    Site contact: Jessica Altman, MD · jaltman@nm.org

  • Indiana University

    Bloomington, IN 47405

    Site contact: Larry Cripe, MD · lcripe@iu.edu

  • Johns Hopkins University

    Baltimore, MD 21218

    Site contact: Corey Tapper, MD · ctapper1@jhmi.edu

  • Massachusetts General Hospital

    Boston, MA 02115

    Site contact: Areej El-Jawahri, MD · 617-724-4000 · ael-jawahri@mgb.org

  • Dana-Farber Cancer Institute

    Boston, MA 02215

    Site contact: Oreofe Odejide, MD, MPH · oreofe_odejide@dfci.harvard.edu

  • Mayo Clinic

    Rochester, MN 55905

    Site contact: Jacob Strand, MD · strand.jacob@mayo.edu

  • University of Rochester

    Rochester, NY 14627

    Site contact: Kah Poh Loh, MD · kahpoh_loh@urmc.rochester.edu

  • University of North Carolina at Chapel Hill

    Chapel Hill, NC 27599

    Site contact: Laura Hanson, MD, MPH · laura_hanson@med.unc.edu

  • Duke University

    Durham, NC 27708

    Site contact: Thomas LeBlanc, MD · Thomas.LeBlanc@duke.edu

  • Ohio State University

    Columbus, OH 43210

    Site contact: Erin Stevens, DO · erin.stevens@osumc.edu

  • Oregon Health & Science University

    Portland, OR 97239

    Site contact: Jason Webb, MD · webbja@ohsu.edu

  • University of Pennsylvania

    Philadelphia, PA 19104

    Site contact: Selina Luger, MD · Selina.Luger@Pennmedicine.upenn.edu

  • Fred Hutchinson Cancer Center

    Seattle, WA 98109

    Site contact: Mohamed Sorror, MD, MSc · msorror@fredhutch.org

  • University of Wisconsin

    Madison, WI 53715

    Site contact: Priyanka Pophali, MD · pophali@wisc.edu

Study contacts (from the official record)

  • Areej El-Jawahri, MD · 617-724-4000 · ael-jawahri@partners.org
  • Chardria S Trotter, MPH, MBA · CTrotter@mgh.harvard.edu
All healthy volunteers studies in Alabama →
Specialty Compared to Oncology Delivered Palliative Care for… (NCT05237258) | Bored Studies